Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model
about
P1343
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approachBiodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.Inhibition of bladder cancer development by allyl isothiocyanate.Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.Current animal models of bladder cancer: Awareness of translatability (Review)Intake of cruciferous vegetables modifies bladder cancer survival.Minimally invasive establishment of murine orthotopic bladder xenograftsKnockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide.Pathobiology and chemoprevention of bladder cancerModelling bladder cancer in mice: opportunities and challenges.Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancerTumor establishment features of orthotopic murine bladder cancer modelsA new method of establishing orthotopic bladder transplantable tumor in mice.Experimental rat bladder urothelial cell carcinoma models.Preconditioning methods influence tumor property in an orthotopic bladder urothelial carcinoma rat model.Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.Animal models of urinary bladder cancer and their application to novel drug discovery.Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.MRI detection of early bone metastases in b16 mouse melanoma models.A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling
P2860
Q30455697-4FAA0717-0072-4452-97D1-5E67E06393B0Q30790817-CDAF8FFC-A14A-4BCB-AEA3-2225F24D807FQ33615332-53E54158-B7DA-4DC7-9E42-E0200BA98EE7Q33625843-A5DF4573-C77D-4D9C-9054-8AC3B3E0012CQ33920324-7FE2C239-4888-44D3-9138-26B6813EF552Q33962620-B9E9E899-293F-4EEC-886D-F0C9A1E075E1Q33981670-8B4FD182-8419-4AAA-B18F-583D115820D5Q34009392-F374DFEA-863C-45A7-A47D-1C47E81C0ED7Q34477376-5367C0F6-D419-41AB-A073-1CBFF3CDC560Q35028770-8E1EBE9F-8D3B-49C5-84A3-49C9DCD6EFBBQ35219328-00B4D676-63B7-408B-A7D7-5E5E05EF3278Q35285703-32A76FA7-396B-4020-B53D-0BDB0853449FQ35440552-6CAC9FED-967D-420E-8D64-16AF14466575Q35739482-B133B077-C1A3-4665-AB9B-032A3319E1BCQ36056998-B410C60A-1477-4782-B246-7CCF097CDB18Q36814459-B571F58B-8D60-413F-AFAE-3FD973163043Q37222356-40B93782-E9FF-4852-B8F8-96960E460A7FQ37560909-45094C84-0B30-4E81-9FA2-9341ABEB95C0Q37622192-9E0BF0DA-9993-40C4-AB7B-4046FCF6D871Q38199547-67937D9E-5724-4A87-80C7-F703DC56D48EQ38901882-16196601-BFC5-422B-A40B-A642F9F9BF62Q42020592-3BAB7677-1468-40D7-A20C-C8FC1B2CCCCAQ44276272-BB19543A-CF2C-4247-9C4D-5EAFFD52FDBEQ53504686-B868AD2D-6F1F-4C0D-A989-9843D5B19B02Q55500236-76A86513-0A94-4558-827A-ECFD0AC584EEQ55714889-B8BEB8CF-B62C-40AB-93B7-F40EF414E1EEQ56992974-A80D13FB-49F7-434C-85D7-BCC05244C52FQ58727488-89FA9463-94D5-4325-B319-6BC84C7BEB83
P2860
Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Characterization of a novel tr ...... transitional cell tumour model
@ast
Characterization of a novel tr ...... transitional cell tumour model
@en
type
label
Characterization of a novel tr ...... transitional cell tumour model
@ast
Characterization of a novel tr ...... transitional cell tumour model
@en
prefLabel
Characterization of a novel tr ...... transitional cell tumour model
@ast
Characterization of a novel tr ...... transitional cell tumour model
@en
P2093
P2860
P356
P1476
Characterization of a novel tr ...... transitional cell tumour model
@en
P2093
McCallum TJ
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690741
P407
P4510
P577
1999-10-01T00:00:00Z